The publication of an unregistered product, known as the “fake registration number A4-9566,” has the attention of the National Agency for Food and Drug Administration and Control (NAFDAC).
The organization revealed in a post on the company’s official X handle on Monday that the product had been produced in China and distributed in Enugu.
NAFDAC officers conducted the discovery through a risk-based sampling survey.
“The product is allegedly produced by Anhui Hongye Pharmaceutical Co., Ltd., a company based in Bengbu, China, and distributed by Gold Vision Medicals, No. Enugu, Nigeria’s Independence Layout, 4 Range Avenue.
During the 2023 RBPMS sampling, three falsified products, namely A-tocin injection, Extocin injection, and Claxitodin injection, were discovered. According to reports, the same company produced the products, and they all bear the same fake NAFDAC Registration Number A4-9566.
NAFDAC Seizes $1. 5 billion worth of banned, expired products at the Lagos Market, read more here.
The organization stated that it is important to take into account that the products identified in this alert are falsified because they are not included in the NAFDAC-registered products database.
NAFDAC issued a risk warning, stating that mothers and newborns are seriously harmed by using unregistered or fabricated oxytocin injections.
The organization warned against incorrect dosages, no active ingredients, or harmful contaminants in such products, which could result in maternal death, postpartum hemorrhage, and ineffective uterine contractions.
The organization warned that “poor-quality oxytocin may also delay or fail to stop bleeding after childbirth, making emergency interventions like blood transfusions or surgery necessary.”
NAFDAC urged consumers and healthcare professionals to remain alert and report any suspicion of a lack of authentic or fake medications to the NAFDAC office closest to them.
The development is a further development in the unregistered drug market.
Prior to now, the organization had raised concerns about the distribution of fake batches of the levonorgestrel-containing emergency contraceptive medication Postinor-2.
Source: Channels TV
Leave a Reply